2010
DOI: 10.1016/j.bmc.2010.04.075
|View full text |Cite
|
Sign up to set email alerts
|

The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 26 publications
0
9
0
Order By: Relevance
“…No parameterization for substituent R 3 has been done. However, all the points fit well to the Equation (18). Compound 10 has the second lowest log1/IC 50 value within the dataset.…”
Section: Konstantinidou and D Hadjipavlou-litinamentioning
confidence: 74%
See 1 more Smart Citation
“…No parameterization for substituent R 3 has been done. However, all the points fit well to the Equation (18). Compound 10 has the second lowest log1/IC 50 value within the dataset.…”
Section: Konstantinidou and D Hadjipavlou-litinamentioning
confidence: 74%
“…Although corticosteroids are established immunosuppressive agents, their action is not selective and they cause metabolic and endocrinal side effects [9], whereas compounds with IL-5 inhibitory activity act selectively in reducing eosinophilic inflammation. In the literature small molecules are referred as IL-5 inhibitors (Figure 1): chalcones [10,11], isothiazolones through modification of Cys66 (Cysteine66) in IL-5Ra (interleukin 5 receptor subunit alpha) [12], isoflavonones as sophoricoside analogues [13,14], hydroxyalkylaminomethylchromones [15], derivatives based on hydroxyethylaminomethyl-4H-chromen-4-one scaffold [16], chromone analogues [17], isoflavones and aurones [18]. Mepolizumab and reslizumab, two monoclonal anti-IL-5 antibodies, and benralizumab, a monoclonal antibody directed at the IL-5 receptor, have been tested in clinical trials for the treatment of bronchial asthma, nasal polyposis, atopic dermatitis, eosinophilic oesophagitis, hypereosinophilic syndrome and Churg-Strauss syndrome [19].…”
Section: Introductionmentioning
confidence: 99%
“…The following reductive elimination of Pd from the palladacycle leads to the desired aurone 47 in its (Z)-predominant isoform, while the resulting reduced Pd(0) is reoxidized by oxygen from air, thus maintaining the catalytic efficiency of the system (Scheme 7) Scheme 6. Cyclization of chalcones according to Thanigaimalai and Yang [59].…”
Section: Cyclization Of Chalconesmentioning
confidence: 99%
“…Additionally, Thanigaimalai and Yang pursued the cyclization of chalcones by exploiting thallium (III) nitrate in methanol solution followed by the addition of hydrochloric acid as the oxidant condition [ 59 ]. Using 1-(2-(cyclohexylmethoxy)-6-hydroxyphenyl)-3-phenylprop-2-en-1-one 41 as the starting material, they obtained either the aurone derivatives 42 or the isoflavone derivatives 43 depending on the substitution pattern on the B ring of the chalcone.…”
Section: Synthetic Strategies To Obtain Auronesmentioning
confidence: 99%
“…Filtration and recrystallization in EtOH yielded the desired aurones (17) [19]. Thanigaimalai and Yang described a synthetic route to aurones via oxidation of 2-hydroxy-6-cyclohexylmethoxychalcones with thallium (III) nitrate (Scheme 6) [20]. In continuation of their previous work [21,22] they treated different chalcones (18) with thallium (III) nitrate in methanol, first at room temperature for 24 h, and then heated to 65°C, followed by addition of hydrochloric acid in a one pot oxidative cyclisation to achieve the corresponding isoflavones (not shown) and/or aurones (19) depending on the electronic nature of substituents on ring B of the chalcones.…”
Section: Synthesis Of Aurone Derivativesmentioning
confidence: 99%